BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 35723442)

  • 1. Immunosonodynamic Therapy Designed with Activatable Sonosensitizer and Immune Stimulant Imiquimod.
    Lei H; Kim JH; Son S; Chen L; Pei Z; Yang Y; Liu Z; Cheng L; Kim JS
    ACS Nano; 2022 Jul; 16(7):10979-10993. PubMed ID: 35723442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Checkpoint blockade and nanosonosensitizer-augmented noninvasive sonodynamic therapy combination reduces tumour growth and metastases in mice.
    Yue W; Chen L; Yu L; Zhou B; Yin H; Ren W; Liu C; Guo L; Zhang Y; Sun L; Zhang K; Xu H; Chen Y
    Nat Commun; 2019 May; 10(1):2025. PubMed ID: 31048681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photothermal-Activatable Fe
    Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
    ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy.
    Lin X; Huang R; Huang Y; Wang K; Li H; Bao Y; Wu C; Zhang Y; Tian X; Wang X
    Int J Nanomedicine; 2021; 16():1889-1899. PubMed ID: 33707944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antitumor immunotherapy using mitochondria-targeted cancer cell membrane-biomimetic MOF-mediated sonodynamic therapy and checkpoint blockade immunotherapy.
    Luo J; Wang X; Shi Z; Zeng Y; He L; Cao J; Sun Y; Zhang T; Huang P
    J Nanobiotechnology; 2022 May; 20(1):228. PubMed ID: 35568916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene augmented nuclear-targeting sonodynamic therapy via Nrf2 pathway-based redox balance adjustment boosts peptide-based anti-PD-L1 therapy on colorectal cancer.
    Wan G; Chen X; Wang H; Hou S; Wang Q; Cheng Y; Chen Q; Lv Y; Chen H; Zhang Q
    J Nanobiotechnology; 2021 Oct; 19(1):347. PubMed ID: 34715867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
    Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
    ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoparticle-Enhanced Radiotherapy to Trigger Robust Cancer Immunotherapy.
    Chen Q; Chen J; Yang Z; Xu J; Xu L; Liang C; Han X; Liu Z
    Adv Mater; 2019 Mar; 31(10):e1802228. PubMed ID: 30663118
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multifunctional nanodrug performs sonodynamic therapy and inhibits TGF-β to boost immune response against colorectal cancer and liver metastasis.
    Huang S; Ding D; Lan T; He G; Ren J; Liang R; Zhong H; Chen G; Lu X; Shuai X; Wei B
    Acta Biomater; 2023 Jul; 164():538-552. PubMed ID: 37037269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfluorocarbon nanodrug induced oxygen self-enriching sonodynamic therapy improves cancer immunotherapy after insufficient radiofrequency ablation.
    Huang T; Wu W; Wu J; Tan Y; Zhang M; Long H; Guo H; Zhang X; Zhou W; Zhang Q; Xie X; Xu M; Zhang C
    Front Immunol; 2023; 14():1124152. PubMed ID: 37051250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Activatable Dual Polymer Nanosystem for Photoimmunotherapy and Metabolic Modulation of Deep-Seated Tumors.
    Liu G; Li J; Wang X; Ren H; Zhang Y
    Adv Healthc Mater; 2024 Apr; 13(9):e2303305. PubMed ID: 38277491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton-Gradient-Driven Porphyrin-Based Liposome Remote-Loaded with Imiquimod as In Situ Nanoadjuvants for Synergistically Augmented Tumor Photoimmunotherapy.
    Liu D; Fu L; Gong L; Li S; Li K; Liu K; Yang D
    ACS Appl Mater Interfaces; 2024 Feb; 16(7):8403-8416. PubMed ID: 38334116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage-derived biomimetic nanoparticles enhanced SDT combined with immunotherapy inhibited tumor growth and metastasis.
    Chen S; Ma T; Wang J; Liang S; Liao H; Tan W; Chen M; Zhou X; Xu Y; Wang L; Niu C
    Biomaterials; 2024 Mar; 305():122456. PubMed ID: 38184961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effective cancer immunotherapy in mice by polyIC-imiquimod complexes and engineered magnetic nanoparticles.
    Bocanegra Gondan AI; Ruiz-de-Angulo A; Zabaleta A; Gómez Blanco N; Cobaleda-Siles BM; García-Granda MJ; Padro D; Llop J; Arnaiz B; Gato M; Escors D; Mareque-Rivas JC
    Biomaterials; 2018 Jul; 170():95-115. PubMed ID: 29656235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
    Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
    J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenic sonodynamic therapy for inducing immunogenic cell death and activating antitumor immunity.
    Wang T; Peng W; Du M; Chen Z
    Front Oncol; 2023; 13():1167105. PubMed ID: 37168380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
    Yasothamani V; Vivek R
    J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell penetrating peptide-modified nanoparticles for tumor targeted imaging and synergistic effect of sonodynamic/HIFU therapy.
    Li Y; Hao L; Liu F; Yin L; Yan S; Zhao H; Ding X; Guo Y; Cao Y; Li P; Wang Z; Ran H; Sun Y
    Int J Nanomedicine; 2019; 14():5875-5894. PubMed ID: 31534329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanodrug with dual-sensitivity to tumor microenvironment for immuno-sonodynamic anti-cancer therapy.
    Huang J; Xiao Z; An Y; Han S; Wu W; Wang Y; Guo Y; Shuai X
    Biomaterials; 2021 Feb; 269():120636. PubMed ID: 33453632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TiSe
    Chen L; Xue W; Cao J; Zhang S; Zeng Y; Ma L; Qian X; Wen Q; Hong Y; Shi Z; Xu Y
    J Nanobiotechnology; 2022 Oct; 20(1):453. PubMed ID: 36243711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.